A recent trial evaluates the impact of dostarlimab on ovarian cancer treatment, revealing modest benefits and no significant safety concerns with niraparib.

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel ...

At ACR 2025, early data of CTA313, a universal CD19/BCMA CAR-T therapy, demonstrate safety and strong responses in refractory ...

Spring Clinical Meetings registration is now open! SCM26 will take place at the New Orleans Ernest N. Morial Convention Center in New Orleans, LA. Pre-conference courses start on May 6, with the ...

I’ll set the scene… Four tweens plus me in my four-person tent, one of whom is particularly scared of the dark. All of us are ...

Naomi Seibt, 25, from Germany , shot to fame in 2019 after her videos challenging climate change went viral, sparking ...

Shoppers face another shake-up as one of Britain’s biggest grocers trims costs and reshapes store services for 2025.

What's needed is an immediate ultimatum from Trump backed by a credible military threat and, beyond that, a realistic plan ...

My role in founding the collective known as Anonymous has gotten me fired and arrested. Right now, the Texas GOP is trying to ...

All products and services featured are independently chosen by editors. However, StyleCaster may receive a commission on ...

Construction tech firm Linarc is offering a 21-day full-platform trial and free lifetime access to its project scheduling ...